• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌的外科手术程序

Surgical procedures for ovarian cancer.

作者信息

Shepherd J H, Crowther M E, Ward B G, Singh P

出版信息

Ann R Coll Surg Engl. 1986 Nov;68(6):315-8.

PMID:2434015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2498298/
Abstract

The management of 191 patients with ovarian cancer is presented. A significant proportion of these patients were initially seen (16%) or operated on (7%) by a general surgeon. The current surgical approach to this disease should be aggressive, and in 23% of these patients a non-gynaecological surgical procedure was required. Although chemotherapy is the main form of treatment following surgery, its chances of success are influenced by the amount of tumour left after surgery. The picture is not uniformly hopeless, and of 34 patients who subsequently underwent laparotomy to check the effectiveness of chemotherapy, 10 (29%) had no evidence of disease. Palliative surgery also has an important place in the management of this disease to provide comfort from disabling symptoms, and in some cases it may prolong life.

摘要

本文介绍了191例卵巢癌患者的治疗情况。这些患者中有相当一部分最初由普通外科医生诊治(16%)或接受手术(7%)。目前针对这种疾病的手术方法应积极主动,其中23%的患者需要非妇科手术。虽然化疗是术后主要的治疗方式,但其成功几率受术后残留肿瘤量的影响。情况并非完全绝望,在随后接受剖腹手术以检查化疗效果的34例患者中,有10例(29%)没有疾病迹象。姑息性手术在这种疾病的治疗中也占有重要地位,可缓解致残症状带来的不适,在某些情况下还可能延长生命。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39d4/2498298/ad6e5750c349/annrcse01541-0025-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39d4/2498298/04c7c794c51d/annrcse01541-0024-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39d4/2498298/d472340fcbc1/annrcse01541-0024-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39d4/2498298/ad6e5750c349/annrcse01541-0025-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39d4/2498298/04c7c794c51d/annrcse01541-0024-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39d4/2498298/d472340fcbc1/annrcse01541-0024-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39d4/2498298/ad6e5750c349/annrcse01541-0025-a.jpg

相似文献

1
Surgical procedures for ovarian cancer.卵巢癌的外科手术程序
Ann R Coll Surg Engl. 1986 Nov;68(6):315-8.
2
The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.全面手术分期在早期上皮性卵巢癌治疗中的益处。
Gynecol Oncol. 2002 May;85(2):351-5. doi: 10.1006/gyno.2002.6636.
3
Platin-based chemotherapy and salvage surgery in recurrent ovarian cancer following negative second-look laparotomy.二次探查剖腹术结果为阴性的复发性卵巢癌患者的铂类化疗及挽救性手术
Acta Obstet Gynecol Scand. 1998 Feb;77(2):233-7.
4
Second-look laparotomy in ovarian cancer.卵巢癌二次剖腹探查术
Gynecol Oncol. 1994 Dec;55(3 Pt 2):S122-7. doi: 10.1006/gyno.1994.1350.
5
Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study.不可切除卵巢癌的新辅助化疗:一项法国多中心研究。
Cancer. 2001 Jun 15;91(12):2329-34.
6
[Current surgical management in ovarian cancer recurrences].[卵巢癌复发的当前外科治疗管理]
Minerva Ginecol. 2004 Oct;56(5):457-67.
7
Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.二次剖腹探查术在卵巢恶性生殖细胞肿瘤的治疗中是否有作用?古斯塔夫·鲁西研究所的经验。
J Surg Oncol. 1996 May;62(1):40-5. doi: 10.1002/(SICI)1096-9098(199605)62:1<40::AID-JSO9>3.0.CO;2-R.
8
Multidisciplinary management of the elderly patient with ovarian cancer.老年卵巢癌患者的多学科管理
Clin Geriatr Med. 1985 May;1(2):345-58.
9
Indicators of survival duration in ovarian cancer and implications for aggressiveness of care.卵巢癌生存持续时间的指标及其对积极治疗的影响。
Cancer. 2008 May 15;112(10):2221-7. doi: 10.1002/cncr.23391.
10
Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.晚期卵巢癌患者二次剖腹探查术中的手术细胞减灭术。
Anticancer Res. 2000 May-Jun;20(3B):1959-64.

本文引用的文献

1
Primary cytoreductive surgery for epithelial ovarian cancer.上皮性卵巢癌的初次肿瘤细胞减灭术
Obstet Gynecol. 1983 Apr;61(4):413-20.
2
Radioimmunodiagnosis of ovarian cancer using 123I-labelled, tumor-associated monoclonal antibodies.使用123I标记的肿瘤相关单克隆抗体对卵巢癌进行放射免疫诊断。
Cancer Detect Prev. 1984;7(1):45-9.
3
The role of cytoreductive surgery in advanced carcinoma of the ovary: an analysis of primary and second surgery.肿瘤细胞减灭术在晚期卵巢癌中的作用:初次手术与二次手术分析
Br J Obstet Gynaecol. 1985 May;92(5):522-7. doi: 10.1111/j.1471-0528.1985.tb01359.x.
4
Management of ovarian carcinoma. Current concepts and future prospects (first of two parts).
N Engl J Med. 1976 Apr 8;294(15):818-22. doi: 10.1056/NEJM197604082941506.
5
Rewiew of ovarian cancer at the University of Texas Systems Cancer Center, M.D. Anderson Hospital and Tumor Institute.德克萨斯大学系统癌症中心、MD安德森医院及肿瘤研究所的卵巢癌综述。
Am J Obstet Gynecol. 1979 Dec 1;135(7):984-93. doi: 10.1016/0002-9378(79)90824-x.
6
Role of cytoreductive surgical treatment in the management of advanced ovarian cancer.减瘤手术治疗在晚期卵巢癌管理中的作用。
Cancer Treat Rep. 1979 Feb;63(2):235-40.